Showing results (1-10 of 168) with videos related to
Sort By:
Pageof 17
Expert Opinion on Biological Therapy|December 2, 2014
Autologous stem cell transplantation in multiple myeloma is not dead but alive and wellMassimo Martino, Fortunato MorabitoExpert Opinion on Biological Therapy|January 8, 2021
An update on B-cell maturation antigen-targeted therapies in Multiple MyelomaMassimo Martino, Annalisa PaviglianitiExpert Opinion on Biological Therapy|March 7, 2014
Long-active granulocyte colony-stimulating factor for peripheral blood hematopoietic progenitor cell mobilizationMassimo Martino, Daniele Laszlo, Francesco LanzaExpert Opinion on Biological Therapy|August 27, 2016
Recommended screening and preventive evaluation practices of adult candidates for hematopoietic stem cell transplantationRoberta Fedele, Nina Salooja, Massimo MartinoExpert Opinion on Biological Therapy|October 16, 2014
Plerixafor: what we still have to learnFrancesco Lanza, Angelo Gardellini, Daniele Laszlo, et al.Current Cancer Drug Targets|May 30, 2013
Optimizing outcomes following allogeneic hematopoietic progenitor cell transplantation in AML: the role of hypomethylating agentsMassimo Martino, Roberta Fedele, Tiziana Moscato, et al.Panminerva Medica|September 21, 2020
Allogenic stem cell transplantation in multiple myeloma: dead or alive and kicking?Massimo Martino, Annalisa Paviglianiti, Massimo Gentile, et al.Frontiers in Oncology|December 2, 2020
Multiple Myeloma Outpatient Transplant Program in the Era of Novel Agents: State-of-the-ArtMassimo Martino, Annalisa Paviglianiti, Mara Memoli, et al.Expert Opinion on Biological Therapy|October 16, 2014
Erythropoiesis-stimulating agents in allogeneic and autologous hematopoietic stem cell transplantationMassimo Martino, Francesco Lanza, Taner Demirer, et al.Recenti Progressi in Medicina|March 14, 2025
[CAR-T cell therapy in a patient with relapsed/refractory mantle cell lymphoma.]Virginia Naso, Filippo Canale, Giorgia Policastro, et al.Pageof 17